Current patent and clinical status of stimulator of interferon genes (STING) agonists for cancer immunotherapy-Reference-Cited by-同舟云学术

Current patent and clinical status of stimulator of interferon genes (STING) agonists for cancer immunotherapy

Published:2019-07 Issue:4 Volume:8 Page:87-90
ISSN:2046-8954
Container-title:Pharmaceutical Patent Analyst
language:en
Short-container-title:Pharmaceutical Patent Analyst

Author:

Marloye Mickaël¹,Lawler Sean E²,Berger Gilles¹²^ORCID

Affiliation:

1. Microbiology, Bioorganic & Macromolecular Chemistry Research Unit, Faculté de Pharmacie, Université libre de Bruxelles (ULB), Boulevard du Triomphe, 1050 Brussels, Belgium

2. Harvey Cushing Neuro-Oncology Laboratories, Department of Neurosurgery, Brigham & Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA

Publisher

Future Science Ltd

Subject

General Medicine

Link

https://www.future-science.com/doi/pdf/10.4155/ppa-2019-0013

Reference36 articles.

1. Hallmarks of Cancer: The Next Generation

2. Enhancement of Antitumor Immunity by CTLA-4 Blockade

3. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death.

4. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion

5. Small-Molecule Targets in Tumor Immunotherapy

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Review on Biological Barriers and Host–Material Interfaces in Precision Drug Delivery: Advancement in Biomaterial Engineering for Better Treatment Therapies;Pharmaceutics;2024-08-16

2. A novel self-assembled nucleobase-nanofiber platform of CDN to activate the STING pathway for synergistic cancer immunotherapy;Colloids and Surfaces B: Biointerfaces;2023-12

3. Recent trends in STING modulators: Structures, mechanisms, and therapeutic potential;Drug Discovery Today;2023-09

4. Functional tumor cell-intrinsic STING, not host STING, drives local and systemic antitumor immunity and therapy efficacy following cryoablation;Journal for ImmunoTherapy of Cancer;2023-08

5. Development of a Kilogram-Scale Synthesis of a Key Ulevostinag Subunit Part II: An Electrophilic Approach to Fluorinated Nucleosides;Organic Process Research & Development;2023-03-07